In a recent retrospective analysis of the IQVIA pharmacy drug dispensing database, how did the epidemiology of benzonatate prescribing in pediatric patients change from 2012 to 2019?
Benzonatate prescribing in pediatric patients increased by 62% from 2012 to 2019 (from ~217,000 unique patients to 351,000) primarily driven by the 10–16-year age group.
Benzonatate Exposure Trends and Adverse Events I. Kim, M. Goulding, F. Tian, S. Karami, T. Pham, C. Cheng, et al. Pediatrics 2022 Vol. 150 Issue 6 Accession Number: 36377394 PMCID: PMC9732921 DOI: 10.1542/peds.2022-057779
Posted in Question Of The Day